Uber Technologies Inc. said it is cutting 23% of jobs in a division that includes human resources, recruitment, workplace ...

Additional data from THIO-101 trial expansion studies may further support a potential Accelerated Approval filing with FDA ...

Nearly a decade later, taking the center stage at ASCO 2026, Akeso’s ivonescimab made history by offering the first-ever ...

Sichuan Kelun-Biotech has announced that first-in-human study data for its novel B7-H3 antibody-drug conjugate SKB500 was presented at the 2026 American Society of Clinical Oncology Annual Meeting in ...

Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. ('Kelun-Biotech' or the 'Company', 6990.HK) announced that at the 2026 ...

Di Wang, PhD, and Y. Shrike Zhang, PhD, of the Division of Engineering in the Mass General Brigham Department of Medicine, are the lead and senior authors of a paper published in Nature Biomedical ...

National Cancer Society Malaysia (NCSM) and Lions Clubs International District 308B1 have signed a memorandum of ...

Lung cancer is the most common and deadly form of cancer worldwide. It is increasingly understood to be a complex genetic disease with different mutations that vary according to factors such as ...

Zoci Intracranial ORR -- Achieved a 62.5% confirmed intracranial overall response rate and nearly 69% best overall ...

Biotech stocks are considered extremely high-risk, high-reward investments. Many biotech companies are developing one or more therapies or technologies that, if effective, could improve treatments ...

Researchers from the Icahn School of Medicine at Mount Sinai have discovered a promising new way to improve CAR-T cell therapy for solid tumors such as lung cancer and melanoma. The study, published ...